Publications

Hawwa, A.F., AlBawab, A., Rooney, M., Wedderburn, L.R. Beresford, M.W., and McELnay, J. C.

Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational cross sectional study.

In press, Arth Res Therapy (Hawwa et al 2015.pdf)

Rothwell, S., Cooper, R.G., Lundberg, I.E., Miller, F.W., Gregersen, P.K., Bowes, J., Vencovsky, J., Danko, K., Limaye, V., O’Callaghan, A.S., Hanna, M.G., Machado, P., Pachman, L.M., Reed, A.M., Rider, L.G., Cobb, J., Platt, H., Molberg, Ø., Benveniste, O., Mathiesen, P., Radstake, T., Doria, A., De Bleecker, J., De Paepe, B., Maurer, B., Ollier, W.E., Padyukov, L., O’Hanlon, T.P., Lee, A., Wedderburn, L.R., Chinoy, H., Lamb, J.A, and the Genetics Consortium (2015).

Dense genotyping of immune-related loci in the Idiopathic Inflammatory Myopathies Confirms HLA alleles as Strongest Genetic Risk Factor and Suggests Different Genetic Background for Major Clinical Subgroups.

Annals R Dis in press (Rothwell et al 2015.pdf)

Tansley, S., and Wedderburn L. R., (2015).

Comparing and contrasting clinical and serological features of juvenile and adult onset dermatomyositis: implications for pathogenesis and outcomes.

Current Opinion Rheumatol, Epub Sep 8. (Tansley and Wedderburn 2015.pdf)

Miller, F. W., Chen, W., O’Hanlon, T.P., Cooper, R.G., Vencovsky, J., Rider, L.G., Danko, K., Wedderburn, L.R., Lundberg, I.E., Pachman, L.M., Reed, A.M., Ytterberg, S.R., Padyukov, L., Selva-O’Callagham, A., Radstake, T., Isenberg, D.A., Chinoy, H., Ollier, W.E.R., Scheet, P., Peng, B., Lee, A., Lamb, A.J., Gregerson, P.K., Amos, C.I with the Myositis Genetics Consortium (2015).

Genome-wide Association Study Identifies HLA 8.1 Ancestral Haplotype alleles as the Major Genetic Risk Factors for Myositis Phenotypes.

Genes and Immunity. Aug 2015. doi: 10.1038/gene.2015.28. [Epub ahead of print]. (Miller et al 2015.pdf)

McCann, L.J., Kirkham, J.J., Wedderburn, L.R., Pilkington, C.A., Huber, A.M., Ravelli, A., Appelbe, D., Williamson, P.R., Beresford, M.W. (2015).

Development of an internationally agreed minimal dataset for Juvenile Dermatomyositis (JDM) for clinical and research use.

Trials Jun 12;16(1):268. (McCann et al 2015.pdf)

Almeida, B., Campanilho-Marques, R., Arnold, K., Pilkington, C.A., Wedderburn, L.R., Nistala, K., behalf of the Juvenile Dermatomyositis Research Group (JDRG).

Analysis of published criteria for Clinically Inactive Disease in a large Juvenile Dermatomyositis cohort shows that skin disease is underestimated.

Arthritis & Rheumatology, 2015 Sep;67(9):2495-502. (Almeida et al 2015.pdf)

Vercoulen, V., Bellutti Enders, F., Meerding, J., Plantinga, M., Elst, E.F., Varsani, H., van Schieveen, C., Bakker, M.H., Klein, M., Scholman, R.C., Spliet, W., Ricotti, V., Koenen, H.J.P.M., de Weger, R.A., Wedderburn, L.R., Royen-Kerkhof, A., Prakken, B.J (2014)

Increased Presence of FOXP3+ Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood

PLOSone 9(8) e105353 (Vercoulen et al 2014.pdf)

McCann, L.J., Arnold, K., Pilkington, C.A., Huber, A.M., Ravelli, A., Beard, L., Beresford, M.W., Wedderburn, L.R. (2014)

Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research

Pediatric Rheumatology 12 :31 (McCann et al 2014.pdf)

Tansley, S., Betteridge, Z.E., Gunawardena, H., Jacques, T.S., Owens, C., Pilkington, C., Arnold, K., Yasin, S., Moraitis, E., Wedderburn, L.R., McHugh, N.J., on behalf of JDRG (2014)

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.

Arthritis Research & Therapy. 16(4) (Tansley et al 2014.pdf)

Jani, M., Massey, J., Wedderburn, L.R., Vencovsky, J., Danko, K., Lundberg, I., Padyukov, L., Selva O’Callaghan, A., Radstake, T., Platt, H., Warren, R.B., Griffiths, C.E., Lee, A., Gregerson P.K., Miller, F.W., Ollier, W.E., Cooper, R.G., Chinoy, H., Lamb, J.A. and EUMYONET (2014)

Genotyping of immune-related genetic variants identifies TYK2 as a novel risk locus for idiopathic inflammatory myopathies.

Annals Rheum Dis. doi: 10.1136/annrheumdis-2014-205440. [Epub ahead of print] (Jani et al 2014.pdf)

6 5 4 3 2 1